Athena Athena

X

Digital content for Jiangsu Recbio Technology

  • Webinars & Exhibitions

PharmaCompass
Send me more info on How To Grow My Bussiness Digitally?
Jiangsu Recbio Technology
China Flag
Country
Country
China
Address
Address
Taizhou, Jiangsu
Telephone
Telephone
Linkedin
Linkedin
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

https://www.prnewswire.com/news-releases/positive-results-in-the-interim-analysis-of-the-clinical-trial-of-recbios-novel-adjuvanted-recombinant-shingles-vaccine-rec610-in-the-philippines-302023639.html

PR NEWSWIRE
28 Dec 2023

https://www.prnewswire.com/news-releases/jiangsu-recbio-technology-co-ltd-announced-2023-interim-results-report-and-latest-progress-301910777.html

PR NEWSWIRE
27 Aug 2023

https://www.prnewswire.com/news-releases/acceptance-of-clinical-trial-application-for-the-recbios-novel-adjuvanted-recombinant-shingles-vaccine-rec610-in-china-and-overseas-clinical-trial-progress-301886939.html

PR NEWSWIRE
26 Jul 2023

https://www.prnewswire.com/news-releases/two-component-recombinant-covid-19-vaccine-recov-granted-with-emergency-use-authorization-in-mongolia-301776938.html

PR NEWSWIRE
21 Mar 2023

https://www.prnewswire.com/news-releases/clinical-trial-approval-for-the-companys-novel-adjuvanted-recombinant-shingles-vaccine-rec610-in-the-philippines-301705875.html

PRNEWSWIRE
19 Dec 2022

https://www.prnewswire.com/news-releases/superior-results-of-the-comparative-study-of-the-companys-recombinant-two-component-covid-19-vaccine-recov-as-compared-to-international-mainstream-mrna-vaccine-301702595.html

PRNEWSWIRE
14 Dec 2022

https://www.prnewswire.com/news-releases/jiangsu-recbio-technology-co-ltd-increases-production-for-the-first-phase-of-manufacturing-facility-with-a-maximum-annual-output-of-20-million-doses-of-recombinant-hpv-9-valent-vaccine-301683614.html

PRNEWSWIRE
21 Nov 2022

https://www.fiercebiotech.com/biotech/recbio-inks-oct-clinical-phase-3-sars-trial

Joseph Keenan FIERCEBIOTECH
13 Sep 2022

https://www.prnewswire.com/news-releases/recbio-announces-interim-results-for-the-fiscal-year-2022-and-company-progress-301613582.html

PRNEWSWIRE
29 Aug 2022

https://www.prnewswire.com/news-releases/completion-of-subject-enrollment-and-vaccination-for-the-comparative-study-between-recov-and-mrna-vaccines-301608999.html

PRNEWSWIRE
18 Aug 2022
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY